Short answer
STANDARD BIOTOOLS INC. (LAB) filed an 8-K current report with the SEC on June 3, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). 500,000 RSUs awarded to Chief Business Officer Sean Mackay under the 2026 Equity Incentive Plan.
STANDARD BIOTOOLS INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- 500,000 RSUs awarded to Chief Business Officer Sean Mackay under the 2026 Equity Incentive Plan
- Vesting schedule: 40% on June 20, 2027 and 60% on June 20, 2028
- Award requires continued service, supporting executive retention through 2028
- Change-of-control and severance protections apply under Mackay’s participation agreement
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other STANDARD BIOTOOLS INC. 8-K filings
Get the next LAB 8-K as it lands
Follow LAB for push alerts, or ask the research agent what this filing means.